In the BioHarmony Drug Report Database
Vinorelbine
Navelbine (vinorelbine) is a small molecule pharmaceutical. Vinorelbine was first approved as Navelbine on 1994-12-23. It is used to treat breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, and ovarian neoplasms in the USA.
Trade Name
|
Navelbine |
|---|---|
Common Name
|
vinorelbine |
ChEMBL ID
|
CHEMBL553025 |
Indication
|
breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, ovarian neoplasms |
Drug Class
|
Vinca alkaloids |
Image (chem structure or protein)